SUMMARY. Eleven strains of the avian pathogen Mycoplasma synoviae were evaluated for the presence of sialidase activity with the use of the fluorogenic substrate 29-(4-methylumbelliferyl)-a-D-N-acetylneuraminic acid and the sialidase inhibitor 2-deoxy-2,3-didehydro-N-acetylneuraminic acid. The kinetics of in vitro growth in modified Frey medium were also assessed for each strain. Five strains had been isolated from clinically symptomatic chickens, and strains WVU1853
Mycoplasma synoviae causes osteoarthritis, synovitis, and respiratory tract lesions in gallinaceous birds (18, 21, 23) . Infection can produce disease that ranges from subclinical to severe. Clinical manifestations vary by strain, and some appear to have a greater tropism for synovial membranes or the respiratory tract than others (21) . Disease is often complicated by co-infection with other pathogens, most notably Newcastle disease virus, infectious bronchitis virus, infectious bursal disease virus, Escherichia coli, Mycoplasma gallisepticum, and Mycoplasma meleagridis (11, 20, 32, 37, 38) . The molecular basis of M. synoviae virulence is not well understood.
The recently annotated genome of M. synoviae field isolate 53 included six genes associated with sialic acid scavenging and degradation (39). Sialidase (EC 3.2.1.18) activity is common in other pathogens and has been associated with bacterial colonization, extracellular matrix degradation, nutrition, dissemination, and induction of apoptosis (7, 15, 19, 25, 40) . The enzyme catalyzes hydrolysis of a-(2-3)-, a-(2-6)-, and a-(2-8)-glycosidic linkages of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrates. Sialidase activity is rare in mycoplasmas, however, possibly because of the utilization of sialic acid residues for attachment to host epithelial cell surfaces by many species of mycoplasma (10, 31, 33, 35 ). An extracellular neuraminidase-like activity was described in an unidentified strain of M. gallisepticum (27,34), and cell-surface sialidase activity of M. gallisepticum strain TT was characterized in detail (36) . The M. gallisepticum strain R genome encodes a putative protein (MGA_0329) identical in sequence to MS53_0199, the predicted sialidase from M. synoviae (30,39), but sialidase activity was absent from other strains of M. gallisepticum (12,17). The hypervirulent Mycoplasma alligatoris A21JP2
T is the only extant isolate in which sialidase activity has been demonstrated (4). The activity is congruous with the invasiveness of M. alligatoris, which is rapidly fatal to susceptible hosts, in contrast to the chronic epithelial lesions observed during typical mycoplasmal infections (3) . Therefore, the discovery of a putative sialidase gene in an isolate of M. synoviae was remarkable for at least three reasons: M. synoviae is phylogenetically distant from M. gallisepticum within the class Mollicutes (16), it is in the same phylogenetic cluster as M. alligatoris, although M. synoviae is less virulent, and sialic acid degradation pathways are absent from the other annotated Mycoplasma spp. genomes. Although M. synoviae field isolate 53, the strain used for determining the genome sequence C (39), was not readily available for phenotypic analysis, we assessed the type strain WVU1853
T and 10 additional clinical isolates of M. synoviae for sialidase activity to support the annotation of MS53_0199 as a sialidase in M. synoviae and to examine possible correlations of sialidase activity with in vitro growth rate and virulence of the organism.
MATERIALS AND METHODS
Mycoplasma synoviae strains. Clinical features of the strains examined are summarized in Table 1 . Strain WVU1853
T has been most commonly reported to cause airsacculitis and synovitis (21); however, experimental infection studies indicated that this strain is capable of systemic spread and the generation of lesions in multiple tissues (13,23). Strain K3344 was isolated during an outbreak of apparent reproductive disease in a breeder flock in 1992 but was demonstrated to produce respiratory lesions during experimental infections (8) . Strains MS117, MS173, and MS178 were isolated during an outbreak of severe synovitis in Argentina (5). Lesions from infected birds involved synovial membranes, bursa of Fabricius, liver, kidney, and the lower respiratory tract in breeders (6) . Strain F10-2AS was associated with respiratory lesions, most notably airsacculitis, in experimentally infected birds (21, 23) . The FMT strain, originally isolated from chicken trachea, induced minor respiratory lesions after experimental infection (23); stocks FMT33 and FMT126 were derived from serial in vitro passages (n 5 33 and 126, respectively) of FMT. Strains K4907A, K5016, K5113, and K5599A were isolated from clinically normal chickens and are not suspected to cause significant lesions. For this study, the species identity of each stock culture was confirmed by polymerase chain reaction amplification and partial sequencing of the 16S rDNA gene by methods described previously (2).
Comparative growth rate. The M. synoviae strains were grown in modified Frey medium (MFM) including 1% (w/v) glucose, 15% (v/v) porcine serum, 0.05% (w/v) L-cysteine, and 0.05% (w/v) nicotinamide adenine dinucleotide (9) . Triplicate cultures were synchronized by dilution with MFM to an initial optical density (A 600 ) of 7 6 5 3 10
24
. All strains were incubated at 37 C in 5% (v/v) CO 2 without agitation, and aliquots were withdrawn every 24 hr for 120 hr to measure A 600 and the concentration (colony-forming units [CFUs]). To determine CFUs, an aliquot of each culture was serially diluted 10-fold in MFM and inoculated onto modified Frey agar. The CFUs were counted after 4 d of incubation.
Sialidase assays. Whole M. synoviae cells from broth cultures in early log-phase growth, as detected by acidification of the MFM, were pelleted by centrifugation for 1 hr at 14,000 3 g and washed with phosphate-buffered saline. Detection of sialidase activity in washed cells and cell-free supernatant fluid was performed as previously described (14) after a 15-min incubation with the fluorogenic substrate 29-(4-methylumbelliferyl)-a-D-N-acetylneuraminic acid (MUAN). The intensity of cyan fluorescence at 450 nm, excited at 365 nm with a cutoff filter at 420 nm, was proportional to sialidase activity (41) . The specificity of the activity was confirmed by co-incubation of M. synoviae cells with 0.35% (w/v) MUAN plus 5 mg/ml of the sialidase inhibitor 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA). Positive and negative controls for the sialidase assay were M. alligatoris and Mycoplasma crocodyli, respectively (4). The amount of sialidase activity per CFU was calculated from a standard curve generated by similar incubation of 1-100 mg/ml (0.77-77 mU/ml) type VI Clostridium perfringens neuraminidase (Sigma-Aldrich, St. Louis, MO) with MUAN.
Statistical procedures. The effect of M. synoviae strain on culture density and sialidase activity (n 5 3 independent replications each) was analyzed by analyses of variance and by the Fisher protected least significant difference test for post hoc comparisons when main effects were significant with StatView version 5.0.1 (Abacus Concepts Inc., Berkeley, CA). An association between culture density and sialidase activity was tested at each time point by non-parametric Spearman rank correlation analysis. Values of P , 0.05 were considered significant.
RESULTS
Mycoplasma synoviae species confirmation. The 16S rDNA sequence of each of the stock cultures examined in this study was determined and confirmed by BLAST (Basic Local Alignment Search Tool) analyses to be identical to that of M. synoviae field isolate 53 and the type strain WVU1853
T (GenBank accession numbers AE017245 and X52083, respectively).
Growth rate. The mean initial culture density was 507 6 21 CFU/ml. In each of three independent replications, strains FMT126, K3344, and MS117 reached a higher (P , 0.0001) culture density than all other strains by 48 hr, although the culture density of strain WVU1853 T exceeded (P , 0.0001) all other strains at 72, 96, and 120 hr. Strains MS173, MS178, FMT33, K4907A, K5016, K5113, and K5599A did not differ significantly from each other at any time point (Fig. 1) . Across all time points, the correlation (P , 0.0001) between mean A 600 and mean density (CFU/ml) ranged among strains from 0.49 to 0.97, with weakest correlations for the fastest-and slowest-growing strains.
Sialidase activity of clinical isolates of M. synoviae. Across strains, MUAN cleavage was inhibited 20-fold (P , 0.0001) by the addition of DANA, providing independent evidence that the fluorescence measured was proportional specifically to sialidase activity. All M. synoviae strains displayed cell-associated sialidase activity. The activity varied 65-fold (P , 0.0001) among strains, ranging from 2.0 3 10 29 to 1.3 3 10 27 U/CFU ( Table 1 ). The group of strains WVU1853 T , F10-2AS, K3344, MS117, MS173, and MS178, originally isolated from clinically symptomatic birds, had more (P , 0.05) sialidase activity than the group of strains K4907A, K5016, K5113, and K5599A from asymptomatic birds. The strain that eventually attained the highest culture density, WVU1853 T , also exhibited the most sialidase activity, but across strains, the rank correlations of culture density with sialidase activity were not statistically significant. Negligible activity was detected in conditioned culture supernatant fluid.
DISCUSSION
In this study, the type strain WVU1853
T of M. synoviae and all additional isolates examined were demonstrated to have sialidase activity. Negligible activity was detectable in conditioned culture supernatant fluid, which is consistent with the conclusion by Roberts (34) that the M. gallisepticum sialidase is extracellular surface associated. Strain WVU1853
T had the most sialidase activity and attained the highest culture density, but although free sialic acid can serve as a nutritional substrate for some bacteria (7, 26) , it seems unlikely to have been rate-limiting in the rich glucose-and serumsupplemented MFM required to support in vitro growth of M. synoviae.
This is the first report that sialidase activity is common among strains of M. synoviae. The activity was higher among more pathogenic isolates. The highest level of sialidase activity observed was for strain WVU1853 T , which was associated with severe systemic disease in experimentally infected birds (13). Intermediate levels of sialidase activity were observed for F10-2AS, a strain associate with respiratory lesions (23); FMT33 and FMT126, whose parent isolate FMT induced respiratory lesions and embryo lethality in chickens (22,23); MS117 and MS178, which originated from an outbreak of severe synovitis (5,6); and strain K3344, which was associated with respiratory lesions in experimentally infected chickens (8) . Low levels of sialidase activity were observed for strains K4907A, K5016, K5113, and K5599A, which were not associated with pathologic lesions. Neither sialidase activity nor clinical data have been reported for strain 53, a field isolate whose complete genome sequence appears to encode all elements of the canonical bacterial sialic acid scavenging and degradation pathway (7, 39) . The association suggests a potential enzymatic mechanism for virulence of the organism because sialylation normally protects against hydrolysis of the glycosidic or peptide bonds of oligosaccharides, glycoproteins, and glycolipids located on host cell surfaces and against degradation of the host's extracellular matrix. It has also been proposed that bacterial desialylation of host glycoconjugates could expose or form new host antigens to play a role in autoimmune complications of infection (17, 19) . The majority of studies examining the virulence of M. synoviae have focused on cytadherence, hemadsorption, or both, with particular attention paid to antigenically variable hemagglutinins (1, 28) . More recently, work by Lockaby et al. (24) , who examined the relationship between virulence of M. synoviae isolates and their cytadherence capabilities, indicated that additional virulence factors are likely because cytadherence did not completely correlate with pathogenicity. It is also noteworthy that the amount of sialidase activity remained virtually unchanged after 93 in vitro passages of M. synoviae strain FMT33 (Table 1) . Hunt and Brown (15) showed that co-incubation with DANA protected cultured pulmonary fibroblasts from M. alligatoris-induced apoptosis. However, incubation with purified C. perfringens sialidase alone did not induce apoptosis, suggesting that interaction of sialidase with another virulence factor or other factors is necessary to elicit the pro-apoptotic effects of M. alligatoris infection (14).
The presence of sialidases in both M. synoviae and M. alligatoris of the M. synoviae phylogenetic cluster indicates that it might be a common characteristic of those related species. However, M. crocodyli, a third member of the cluster having comparatively attenuated virulence, does not exhibit sialidase activity (4), so it might be of substantial value to examine additional members of the cluster to elucidate the role of sialidase in pathogenesis that cannot be attributed to cytadherence. The amount of sialidase activity varied 65-fold among M. synoviae strains, suggesting that the enzymes in the sialic acid scavenging pathway could be susceptible to genetic heterogeneity or variable in copy number. Experimental infection studies employing disruption of the genes required for this activity might be necessary for definitive demonstration of the role of sialidase in the virulence of M. synoviae. T ) were grown in MFM at 37 C in 5% (v/ v) CO 2 without agitation. Triplicate cultures were initially synchronized by dilution with MFM to 507 6 21 CFU/ml. Aliquots were withdrawn every 24 hr for 120 hr to measure culture density. Strains FMT126, K3344, and MS117 reached a higher (P , 0.0001) density than all other strains by 48 hr, although the density of strain WVU1853 T exceeded all other strains at 72, 96, and 120 hr.
